Preliminary study results of ExThera Medical’s Seraph extracorporeal affinity therapy published...

Preliminary study results of ExThera Medical’s Seraph extracorporeal affinity therapy published ExThera Medical announced today that the results of a preliminary study (“Cytokines in blood from septic patients interact with surface immobilized heparin”) of its proprietary medical device, Seraph™ extracorporeal affinity therapy, have been published in the current issue of the Journal of the American Society...